The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLSAI.L Regulatory News (LSAI)

  • There is currently no data for LSAI

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update and Directorate Changes

11 Feb 2021 07:00

RNS Number : 6873O
Location Sciences Group PLC
11 February 2021
 

11 February 2021

 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Regulation 11 of the Market Abuse (Amendment) (EU Exit) Regulations 2019/310 ("MAR"). With the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

 

Location Sciences Group PLC("Location Sciences" or the "Company")

 

Trading Update and Directorate Changes

 

 

Location Sciences (AIM: LSAI), the leading location data insight and verification company, provides the following trading update for the year ended 31 December 2020.

 

Trading Performance

 

Unaudited revenues for the year ended 31 December 2020 are expected to be approximately £1.07 million, a decrease of approximately 12% on 2019 (2019: £1.21 million). The reduction in revenue is due to the ongoing impact of the COVID-19 pandemic on the location-based advertising industry.

 

Unaudited Verify revenues for the year to 31 December 2020 were £0.32 million, compared to £0.50 million in 2019, a reduction of 36%.

 

Unaudited Data & Insights revenues showed a modest improvement, delivering £0.75 million for the year to 31 December 2020, a 6% increase on 2019 (2019: £0.71 million).

 

To mitigate the impact of COVID-19, the Company's directors implemented a cost reduction programme in early 2020 which has led to unaudited administrative expenses being reduced to approximately £1.50 million for the year, a reduction of 41% on 2019 (2019: £2.55 million).

 

The unaudited EBITDA loss is expected to be approximately £0.77 million in the full year period, a decrease of approximately 55% compared to 2019 (2019: EBITDA loss £1.71 million).

 

Impact of COVID-19

 

Verify revenues have continued to be adversely impacted by the significantly reduced advertising spend caused by the pandemic. The anticipated uplift in Verify revenues during Q4 2020 did not materialise and there has been no improvement in the first part of 2021 due to the ongoing restrictions being imposed by governments globally.

 

As reported during 2020, it has been a challenging time for location-based advertising within sectors that rely on people's movement, such as retail and QSR.

 

The outlook for location-based advertising is poor due to the overall impact of the pandemic on the location-based advertising industry, with mainstream media agencies now focused on media delivery rather than adopting new technologies, especially those which risk limiting delivery scale such as Verify.

 

Data & Insights

 

As reported in our interim results, the Company has sought to mitigate the loss of Verify revenues by enlarging and broadening its Data & Insights customer base, including helping to inform the ongoing response to COVID-19. Through its long-term partnership with CACI, Location Sciences is supplying data to support NHS England and members of the Scientific Pandemic Influenza Group on Modelling (SPI-M) in their analysis of how movement of individuals is impacting the reproduction number (R) and growth rate of COVID-19 in the UK.

 

These contract wins enabled the Data & Insights business to grow modestly during 2020, despite the negative impact of the pandemic on some of the business's existing customers.

 

During 2020, the Company developed a new product for the financial services industry which it expects to launch on the Bloomberg Enterprise Access point in the next few months. The product will provide financial analysts with access to market leading footfall data and insights for UK supermarkets to assist them to better measure store performance. A further announcement will be made upon launch of this new product.

 

Verify Status

 

The Company launched an updated version of its Verify Proximity platform at the end of April 2020, providing customers with a clearer picture of how to obtain better value from their location spend and how to drive better performance. Following this in June 2020, Location Sciences launched its Verify Audience product "GeoProtect" in the US. GeoProtect allows brands, agencies and suppliers to check the validity of location-based derived audience segments. It also enables a review of historical movements in contrast to proximity which validates the real time locations as digital advertising campaigns are delivered.

 

Since GeoProtect's launch, the Company has made two important customer wins, both of which were announced in 2020. InMarket, which is a leader in 360-degree consumer intelligence business in the US, and The Spoken Thought, Inc. (trading as Mira), which is a high value audience segment supplier to leading brands and media agencies across the US. Both contracts have growth potential but are facing headwinds in the US market due to the ongoing impact of the pandemic.

 

Despite the product enhancements, the broadening of the product offering with GeoProtect, and the key customer wins during 2020, the performance of Verify has been severely hampered by the restrictions imposed by governments globally to tackle the ongoing pandemic.

 

Further to these developments, in December 2020 shareholders were advised of potential defamation action against the Company pursuant to data manipulation identified by Verify and the findings being reported to its customers. While the threatened legal action - which the Company believes is baseless - has not transpired, the reaction from industry participants has been disappointing. The reality being that the location-based advertising industry is reluctant to adopt technologies which bring transparency to this area, especially now, given the negative impact of the pandemic.

 

The Company will continue to try and solve what it sees as an industry problem. However, the directors believe that, as a knock-on impact of the pandemic, it may now be some years before the location-based advertising industry fully embraces transparency.

 

Cash Resources

 

In March 2020, the Company raised approximately £0.975 million (before expenses) through an equity placing comprising the issue and allotment of 111,430,000 new ordinary shares. An additional approximately £0.07 million was raised through the issue and allotment of 74,057,996 new ordinary shares pursuant to the issue of warrants.

 

In addition to the fundraising activities, the Board made swift cost reductions to mitigate the impact of the downturn in revenues. These included salary reductions for the Board and senior members of the team, a hiring freeze, closure of the London office and staff being furloughed. In addition, with the exception of product development, all operational expenses were reduced to the minimal viable levels from April 2020 following the downturn in the location-based advertising industry caused by the restrictions imposed by governments globally. These actions, together with the data and insight customer wins during the year, have to a large extent offset the impact of the lower Verify revenues on the cash resources of the business.

 

As at 31 December 2020, the Company had cash reserves of approximately £1.1 million (2019: £1.3 million), which the directors believe will now be sufficient for the Company's requirements until 2022.

 

Board Changes

 

In recognition of the need for a leaner business going forward, the size of the Board has been reduced and the Company announces that both Donald Williams and Niall Hogan are stepping down from the Board with immediate effect.

 

The Board would like to thank both Donnie and Niall for their valuable contributions and consider them friends of the Company going forward.

 

Business Review

 

The Board believes that, in part as a consequence of COVID-19, the Company and in particular, Verify, will continue to face a number of trading challenges. This is despite the current relative strength of the Company's working capital position. As a result, the Board is now exploring a number of options for the Company and its businesses and further announcements will be made as and when appropriate.

 

Mark Slade, Chief Executive Officer of Location Sciences, commented: "Like many businesses, 2020 has been an extremely challenging year for Location Sciences and, disappointingly, has halted the momentum we had gained in our verification business. Embracing transparency, which has the side effect of limiting the scale of media delivery, has simply fallen down the priority list for many in the industry. On the positive side, we are encouraged by the durability of our data and insight business and look forward to launching our first product into the financial services industry.

 

"As shown by our results, as a management team we have done everything possible to reduce costs and conserve the cash resources of the business.

 

"The announcement of a business review is the right thing for us to do for shareholders given the ongoing uncertainty caused by the global pandemic and the Board will be evaluating all options open to it."

 

For further information please contact:

 

Location Sciences Group PLC

via Milk & Honey PR

Mark Slade, Chief Executive Officer

 

David Rae, Chief Financial Officer

 

 

 

Allenby Capital Limited (Nominated Adviser)

Tel: +44 (0)20 3328 5656

David Hart

 

 

 

Peterhouse Capital (Broker)

Charles Goodfellow

Eran Zucker

Tel: +44 (0) 20 7220 9791

 

Milk & Honey PR

Tel: +44 (0)20 3637 7310

Kirsty Leighton

 

Jessica Ballinger

 

 

About Location Sciences Group PLC:

 

Location Sciences is a leading independent location data insight and verification company based in the UK.

 

Location Sciences has developed the world's first truly independent location verification solutions, Verify and GeoProtect. Working in partnership with brands, media agencies and suppliers, Location Sciences helps to reduce ad-wastage and improve the effectiveness of location-based advertising campaigns.

 

Location Sciences data and insights products assist companies connecting the digital world with the physical world using mobile location technology data. By combining cutting-edge mobile location data with proprietary machine learning analytics Location Sciences provides customers innovative and valuable insights from location information.

 

Rule 26 website: www.locationsciencesgroup.ai

Verify website: www.locationsciences.ai

LinkedIn: https://www.linkedin.com/company/locationsciences

Twitter: @LocationSci

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCVBLFFFLLBBBV
Date   Source Headline
16th Feb 202412:30 pmRNSResult of General Meeting
6th Feb 202410:55 amRNSHolding(s) in Company
30th Jan 20248:00 amRNSSchedule One - Location Sciences Group Plc
30th Jan 20247:30 amRNSRestoration - Location Sciences Group PLC
30th Jan 20247:00 amRNSAcquisition and Publication of Admission Document
25th Jan 20247:00 amRNSLoan Facility and Holding in Company
20th Dec 20237:00 amRNSFurther update on proposed acquisition of Sorted
6th Oct 20237:00 amRNSUpdate on proposed acquisition of Sorted
14th Sep 20237:00 amRNSHalf-year Report
28th Jul 20231:22 pmRNSResult of AGM
25th Jul 20237:00 amRNSHolding(s) in Company
28th Jun 20237:30 amRNSSuspension - Location Sciences Group plc
28th Jun 20237:00 amRNSLoan Agreement, Proposed Acquisition & Suspension
26th Jun 20237:00 amRNSAnnual Financial Report
11th Apr 20234:56 pmRNSHolding(s) in Company
31st Mar 202311:50 amRNSHolding(s) in Company
27th Mar 20237:00 amRNSHolding(s) in Company
22nd Mar 20233:47 pmRNSHolding(s) in Company
22nd Mar 20231:40 pmRNSHolding(s) in Company
22nd Mar 20239:05 amRNSSecond Price Monitoring Extn
22nd Mar 20239:00 amRNSPrice Monitoring Extension
15th Mar 20234:35 pmRNSPrice Monitoring Extension
9th Mar 20234:35 pmRNSPrice Monitoring Extension
27th Sep 20227:00 amRNSHalf-year Report
30th Jun 202211:56 amRNSResult of AGM
6th Jun 20227:00 amRNSNotice of Annual General Meeting
1st Jun 20222:12 pmRNSDirector/PDMR Shareholding
1st Jun 20221:25 pmRNSDirector/PDMR Shareholding
1st Jun 20227:00 amRNSBoard and strategic update
5th Apr 202211:05 amRNSSecond Price Monitoring Extn
5th Apr 202211:00 amRNSPrice Monitoring Extension
30th Mar 20227:00 amRNSAnnual Financial Report
1st Feb 20227:00 amRNSFurther re Sale of Insights dashboard
24th Jan 202211:05 amRNSSecond Price Monitoring Extn
24th Jan 202211:01 amRNSPrice Monitoring Extension
22nd Oct 20218:05 amRNSSale of Insights dashboard
27th Sep 202112:09 pmRNSHalf-year Report
21st Jun 20211:27 pmRNSBusiness Review update and proposed Board changes
21st Jun 202111:28 amRNSHolding(s) in Company
18th Jun 202110:55 amRNSResult of AGM
11th Jun 202110:34 amRNSHolding(s) in Company
8th Jun 202111:54 amRNSHolding(s) in Company
1st Jun 20219:06 amRNSSecond Price Monitoring Extn
1st Jun 20219:00 amRNSPrice Monitoring Extension
28th May 20215:00 pmRNSTotal Voting Rights
28th May 20212:11 pmRNSHolding(s) in Company
27th May 20213:33 pmRNSTR-1 Notification of major holdings
25th May 20218:05 amRNSNotice of AGM
25th May 20218:01 amRNSBoard changes and appointment of Joint Broker
21st May 202111:14 amRNSGM Result, Issue of Equity and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.